isoxazoles has been researched along with Aortic Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banyard, D; Beazley, KE; Deasey, SC; Konoplyannikov, M; Lima, F; Nurminskaya, MV; Nurminsky, DI | 1 |
Deuse, T; Hoyt, G; Koyanagi, T; Robbins, RC; Schrepfer, S | 1 |
2 other study(ies) available for isoxazoles and Aortic Diseases
Article | Year |
---|---|
Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.
Topics: Animals; Aorta; Aortic Diseases; beta Catenin; Blood Pressure; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; GTP-Binding Proteins; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Osteogenesis; Phosphorylation; Protein Glutamine gamma Glutamyltransferase 2; Quercetin; Rats; Rats, Wistar; Signal Transduction; Transglutaminases; Vascular Calcification; Warfarin | 2013 |
Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778.
Topics: Alkynes; Animals; Aorta; Aortic Diseases; Chronic Disease; Cyclosporine; Immunosuppressive Agents; Isoxazoles; Male; Nitriles; Rats; Rats, Inbred ACI; Transplantation, Homologous | 2008 |